Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Cutera GenesisPlus laser system receives Canada approval

Cutera, a provider of laser and light-based aesthetic systems, has received Canada approval for its GenesisPlus laser system to treat onychomycosis (nail fungus), warts and scars.

GenesisPlus uses Cutera’s patented microsecond technology and has a proprietary delivery system with a temperature sensor which aids to improve practitioner and patient experience.

The laser systyem is also used to treat wrinkles, vascular lesions, pigmented lesions, warts and accelerates scar remodeling, including surgical, hypertrophic and keloid scars.

Cutera president and CEO Kevin Connors said they are pleased that, with the recent Health Canada approval, GenesisPlus is now available to physicians throughout US, Canada and Europe.